NEW YORK, July 18, 2016—Kantar Health, a leading global healthcare consulting and market research firm, today announced it is expanding its presence in Israel to better partner with companies in the country’s rapidly growing life sciences industry. As part of this expansion Kobi Sharon has been named Vice President, Client Consulting, and is based in Israel.
Israel is home to 280 global, multinational research and development centers that employ about 45% of the country’s high-tech workforce. Kantar Health will offer its marketing insights and real-world evidence solutions to the multinational corporations and local biotech, medical technology and mHealth companies that populate Israel’s hub of healthcare innovation. These solutions include:
- Filling and identifying the gaps in disease management
- Demonstrating value for their products – commercially and clinically
- Ensuring regulatory, efficacy and safety requirements are fulfilled
- Driving and maximizing brand performance
- Mapping and leveraging the patient journey
“Israel is a unique market because it’s a very small country, but the number of biotech and multinational companies in life sciences is amazing,” Sharon said. “These companies are looking not only locally but also globally and need insights to maximize the opportunities for their products and solutions. By having an increasing presence in Israel, Kantar Health is ideally situated to partner with these companies and provide them with actionable insights to capitalize on their business opportunities.”
About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.
Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 600+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. Kantar Health is part of Kantar, the data investment management division of WPP. For more information, please visit www.kantarhealth.com.